Abstract: By detecting an antibody which immunologically reacts with amylase ?2-A in a sample, AIP or FT1DM is examined or the possibility of developing FT1DM is determined. For instance, detection of this antibody is carried out by an immunological method using an antigen which immunologically reacts with this antibody. The antigen is preferably a partial fragment containing the amino acid sequence of amino acid numbers 299 to 511 of human amylase ?2-A (SEQ ID NO: 1).
Type:
Grant
Filed:
May 2, 2008
Date of Patent:
October 2, 2012
Assignees:
University of Yamanashi, Cosmic Corporation
Abstract: By detecting an antibody which immunologically reacts with amylase ?2-A in a sample, AIP or FT1DM is examined or the possibility of developing FT1DM is determined. Detection of this antibody is for instance carried out by an immunological method using an antigen which immunologically reacts with this antibody. The antigen is preferably a partial fragment containing the amino acid sequence of amino acid numbers 299 to 512 of human amylase ?2-A.
Type:
Application
Filed:
May 2, 2008
Publication date:
May 27, 2010
Applicants:
UNIVERSITY OF YAMANASHI, COSMIC CORPORATION